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ABSTRACT
Objective: The use of plants for medicinal remedies is an integral part of the Indian cultural life, and the traditional background of Indian medicine 
shows widespread use of plant products in cancer treatment. In this study, stem extracts of some selected Cassia species have been evaluated for their 
cytotoxic activities under in vitro conditions.
Methods: The stems were shade dried at room temperature. The dried and coarsely powdered plant material were extracted with petroleum ether 
(60-80°C), chloroform, and ethanol using soxhlet apparatus. The cytotoxicity was evaluated by [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide] assay.
Results: Stem extracts of three Cassia species, viz., Cassia glauca, Cassia Obtusifolia, and Cassia sophera have been evaluated for their cytotoxic activities 
with chloroform, ethanol and pet ether against HeLa and breast cancer cell lines. Among the three different solvents used at different concentrations, 
the chloroform extracts of all Cassia species exhibited maximum cytotoxicity (%) against both cell lines. The CTC50 values are revealed the cytotoxic 
potential of C. glauca chloroform extracts against HeLa cell line and breast cancer cell lines with CTC50 values 180.00±3.0 and 146.67±0.5, respectively. 
Chloroform extracts of C. Obtusifolia and C. sophera showed maximum activity against HeLa (380.00±1.1 and 800.00±1.7, respectively) and breast 
cancer cell lines (310.00±1.1 and 633.33±0.6).
Conclusion: The results of this study demonstrate the potent cytotoxic activity of chloroform extracts of stems of Cassia species against HeLa and 
Breast cancer cell lines.
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INTRODUCTION
Plant and plant products both as extracts and derived compounds are 
known to be effective and versatile chemopreventive agents against a 
variety of types of cancers [1]. About 60% of currently used anticancer 
agents are derived from natural sources directly or indirectly [2]. 
Development of several promising new agents in anticancer drug 
therapy such as vinblastine, vincristine, the camptothecin derivatives, 
topotecan and irinotecan, etoposide along with flavopiridol and 
combretastain A4 phosphate from natural sources stimulated 
renewed interest among the biologists in screening the medicinal 
plants in anticancer drug therapy [3,4]. The use of plants for 
medicinal remedies is an integral part of the Indian cultural life, and 
the traditional background of Indian medicine shows widespread use 
of plant products in cancer [5,6]. The members of Cassia species are 
rich sources of polyphenols, anthraquinone derivatives, flavonoids, 
and polysaccharides [7,8], and they have been found to exhibit anti-
inflammatory, antioxidant, hypoglycemic, antiplasmodial, larvicidal, 
antimutagenic, and anticancer activities [9]. In this study, stem extracts 
of some selected Cassia species have been evaluated for their cytotoxic 
activities under in vitro conditions.
METHODS
Plant material and stem extraction
The stems of Cassia glauca, Cassia obtusifolia, and Cassia sophera were 
collected from in and around Bagalkot District of North Karnataka 
region of Southern India. The stems were shade dried at room 
temperature. The dried and coarsely powdered plant material was 
extracted with petroleum ether (60-80°C), chloroform and ethanol 
using soxhlet apparatus. The extracts wee dried under reduced pressure 
at temperature at 30°C to dryness to yield dried extract residue.
Cell lines and culture medium
HeLa and MDA MB 231 (breast cancer) cell lines were procured from 
National Centre for Cell Sciences, Pune, India. Stock cells were cultured 
in DMEM supplemented with 10% inactivated fetal bovine serum (FBS), 
penicillin (100 IU/ml), streptomycin (100 mg/ml), and amphotericin 
B (5 mg/ml) in an humidified atmosphere of 5% CO2 at 37°C until 
confluent. The cells were dissociated with trypsin phosphate versene 
glucose solution (0.2% trypsin, 0.02% ethylenediaminetetraacetic acid, 
0.05% glucose in phosphate-buffered saline [PBS]). The stock cultures 
were grown in 25 cm2 culture flasks, and all experiments were carried 
out in 96 microtitre plates (Tarsons India Pvt. Ltd., Kolkata, India).
Preparation of test solutions
For cytotoxicity studies, each weighed test drugs were separately 
dissolved in distilled dimethyl sulfoxide and volume was made up 
with DMEM supplemented with 2% inactivated FBS to obtain a stock 
solution of 1 mg/ml concentration and sterilized by filtration. Serial 
two-fold dilutions were prepared from this for carrying out cytotoxic 
studies.
Determination of cell viability by 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay
The monolayer cell culture was trypsinized, and the cell count was 
adjusted to 1.0×105 cells/ml using DMEM containing 10% FBS. To 
each well of the 96 well microtitre plate, 0.1 ml of the diluted cell 
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suspension (approximately 10,000 cells) was added. After 24 hrs, 
when a partial monolayer was formed, the supernatant was flicked off, 
washed the monolayer once with medium and 100 ml of different test 
concentrations of test drugs were added on to the partial monolayer 
in microtitre plates. The plates were then incubated at 37°C for 3 days 
in 5% CO2 atmosphere, and microscopic examination was carried out 
and observations were noted every 24 hrs interval. After 72 hrs, the 
drug solutions in the wells were discarded and 50 ml of MTT in PBS 
was added to each well. The plates were gently shaken and incubated 
for 3 hrs at 37°C in 5% CO2 atmosphere. The supernatant was removed 
and 100 ml of propanol was added, and the plates were gently shaken 
to solubilize the formed formazan. The absorbance was measured 
using a microplate reader at a wavelength of 540 nm. The percentage 
growth inhibition was calculated using the following formula and 
concentration of test drug needed to inhibit cell growth by 50% (CTC50) 
values is generated from the dose-response curves for each cell line.
% Growth Inhibition






















MTT assay revealed the cytotoxic activities of stem extracts in different 
solvents against HeLa and MDA MB 231 cell lines. Among the three 
different solvents used at different concentrations, the chloroform 
extracts of all three Cassia species exhibited maximum cytotoxicity (%) 
against both HeLa and MDA MB 231 cell lines. C. glauca chloroform 
extracts showed maximum inhibition against HeLa (85.17%) and MDA 
MB cell lines (78.03%) followed by pet ether extracts (66.15% and 
60.64%) at 1000 mcg/ml (Fig. 1).
C. obtusifolia chloroform extracts showed the highest cytotoxicity against 
HeLa (59.98% and 51.46% at 1000 and 500 mcg/ml, respectively) 
and breast cancer cell lines (66.00% and 55.17% at 1000 and 
500 mcg/ml, respectively). The pet ether extracts C. Obtusifolia did not 
show significant cytotoxicity against both HeLa and breast cancer cell 
lines at 1000 mcg/ml.
C. sophera chloroform extracts exhibited high cytotoxicity against 
HeLa (70.78%) and breast cancer cell lines (69.27%) at 1000 mcg/ml 
concentration. The pet ether extracts of C. sophera showed moderate 
cytotoxicity against HeLa (39.65%) and breast cancer cell lines 
(44.08%) (Fig. 1).
The CTC50 values revealed the cytotoxic potential of C. glauca chloroform 
extracts against HeLa cell line and breast cancer cell lines with CTC50 
values 180.00±3.0 and 146.67±0.5, respectively. The pet ether extracts 
of C. glauca also exhibited the cytotoxicity against HeLa breast cancer 
cell lines with values 750.00±1.2 and 646.67±0.5, respectively. Only 
chloroform extracts of C. Obtusifolia and C. sophera showed maximum 
activity against HeLa (380.00±1.1 and 800.00±1.7, respectively) and 
breast cancer cell lines (310.00±1.1 and 633.33±0.6, respectively 
(Table 1 and Fig. 2).
Fig. 1: Cytotoxicity (%) of plant extracts against HeLa and MDA MB 231 cell lines at different concentrations. (a) Cassia glauca, (b) Cassia 
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Fig. 2: Photographs showing activity against MDA MB 231 cell lines at 1000 concentration in mcg/ml
DISCUSSION
The MTT assay revealed the cytotoxic potential of extracts against 
HeLa and breast cancer cell lines. A number of studies on Cassia 
species revealed the presence of phenols, flavonoids in the plant 
material [10]. The phytochemical studies of Cassia species have 
provided their ethnopharmtment of various diseases due to their 
contents of hydroxyl anthraquinone [11]. Pharmacognostical study 
on C. obtusifolia revealed the presence of tannins, flavonoids, steroids, 
and phylobatannins [12]. Similarly, ethanolic extracts of C. sophera 
proved to be hepatoprotective against carbon tetrachloride induced 
hepatic damage in rats [13]. In a recent study, the hexane extracts of 
the Cassia alata showed remarkable cytotoxicity against breast and 
lung carcinoma cells and the elucidation of hexane extracts revealed 
the presence of polyunsaturated fatty acids esters [14]. In our study, 
the chloroform extracts exhibited maximum cytotoxicity against the 
cell lines in all the plant studied. Different extracts of the plant exhibit 
different activity on different cell lines. This selectivity could be due 
to the sensitivity of the cell lines to the active compounds in the 
extract or to tissue-specific response [15]. However, further work is 
needed in the form of phytochemical screening and pharmacological 
activity of some more extracts about the therapeutic potential of 
these extracts.
Table 1: The CTC50 (µg/ml) values of Cassia species against HeLa 
and MDA MB 123 cell lines
Plant Extract CTC50 (µg/ml)
HeLa MDA
Cassia glauca Pet ether =750.00 ± 1.2 646.67 ± 0.5
Chloroform =180.00 ± 3.0 146.67 ± 0.5
Ethanol >1000 ± 0.00 >1000
Cassia obtusifolia Pet ether >1000 ± 0.00 >1000
Chloroform =380.00 ± 1.1 310.00 ± 1.1
Ethanol >1000 ± 0.00 >1000
Cassia sophera Pet ether >1000 ± 0.00 >1000
Chloroform =800.00 ± 1.7 633.33 ± 0.6
Ethanol >1000 ± 0.00 >1000 ± 0.00
*P < 0.05 Results are means of ± SD of three independent experiments. 
SD: Standard deviation
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